Financing: Page 4

HTG Molecular Diagnostics prices $10M public offering

By LabPulse.com staff writers

HTG uses transcriptome-wide profiling for translational research, novel therapeutics, and clinical diagnostics across a variety of disease areas.

December 22, 2022

Avalon GloboCare announces $4M private placement of shares to support Laboratory Services MSO acquisition

By LabPulse.com staff writers

The proceeds will be used toward the purchase of Laboratory Services MSO, in Costa Mesa, CA. Avalon announced in early November its acquisition of a 60% interest in Laboratory Services MSO.

December 14, 2022

Pictor launches $5M financing round to support product, market development

By LabPulse.com staff writers

Pictor's multiplex technology enables testing for multiple diseases or different stages of a disease within a single enzyme-linked immunosorbent assay (ELISA) test well.

December 5, 2022

PictorLabs closes $15.2M financing to develop AI-based virtual staining platform

By LabPulse.com staff writers

With the additional funds secured in the latest round of financing, PictorLabs intends to expand its biomarker portfolio and develop its products.

December 1, 2022

Sherlock Biosciences secures funding to further develop CRISPR testing platform

By LabPulse.com staff writers

The company said it will use the funding to further develop its CRISPR testing platform, enabling broader testing in low- and middle-income countries.

November 29, 2022

Empatica receives FDA clearance for digital biomarker platform, closes Series B financing

By LabPulse.com staff writers

The platform is used to gather and analyze physiological data for clinical trials evaluating new therapeutics. Empatica is collaborating with researchers on digital biomarkers for use as endpoints.

November 23, 2022

Biodesix secures loan of up to $50M, announces $35.1M stock offering

By LabPulse.com staff writers

The developer of diagnostic tests that combine multiomics through AI said it will use the loan to strengthen its balance sheet, reduce near-term cash use, and enable the continued growth trajectory of its core lung diagnostics business.

November 17, 2022

SQI Diagnostics secures C$2M to support manufacturing, commercialization

By LabPulse.com staff writers

SQI will use the funds to support its manufacturing scale-up and commercialization of its pipeline of products in development, including the Rali-Dx IL-6 test.

November 10, 2022

Virax Biolabs closes $3.8M private placement to support development of T-cell testing technology

By LabPulse.com staff writers

Virax said it will use the net proceeds from the private placement to develop and commercialize its T-cell test technology.

November 9, 2022

Osler Diagnostics raises $85M in Series C financing

By LabPulse.com staff writers

Osler Diagnostics said that the Series C financing will support its portable testing platform, which aims to provide a broad menu of tests.

November 7, 2022

Guardant Health reports 24% rise in third-quarter revenue

By LabPulse.com staff writers

Guardant’s third-quarter revenue was $117.4 million, a 24% increase over $94.8 million for the third quarter of 2021.

November 4, 2022

Veracyte announces Q3 financial results

By LabPulse.com staff writers

Veracyte's third-quarter total revenue was $75.6 million, 25% higher than 2021’s third-quarter revenue of $60.4 million.

November 3, 2022

Previous Page

Page 4 of 8

Next Page